The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The In Situ Hybridization Market Expected To Reach Based On Its 2026 Value?
The in situ hybridization market size has experienced rapid growth in recent years. It is forecast to expand from $1.81 billion in 2025 to $2.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. The historical increase can be attributed to the broadening of molecular pathology research, a rising demand for cancer diagnostics, the expansion of cytogenetic testing applications, the availability of advanced laboratory infrastructure, and the increasing adoption of FISH techniques.
The in situ hybridization market is projected to undergo significant expansion in the upcoming years, with its valuation expected to reach $3.08 billion by 2030, reflecting an impressive compound annual growth rate (CAGR) of 11.3%. This anticipated growth throughout the forecast period is primarily driven by factors such as the increasing demand for personalized medicine diagnostics, the rising integration of AI-based image analysis, the expansion of companion diagnostics applications, growing investments in genomic research, and the increasing use of in situ hybridization in infectious disease detection. Key trends during this period are expected to include the increasing adoption of fluorescence-based hybridization techniques, a rising demand for molecular diagnostic accuracy, the growing use of automated imaging and analysis systems, the expansion of cancer diagnostic applications, and enhanced integration of digital pathology tools.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp
Which Key Drivers Are Affecting The In Situ Hybridization Market Development?
The in-situ hybridization market is anticipated to expand moving forward, primarily fueled by the growing number of infectious diseases. These diseases are defined as conditions that spread between individuals via tainted food and beverages, as well as through pathogens like viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) works by utilizing labeled nucleic acid sequences, known as probes, specific to an infectious organism to detect complementary nucleic acid sequences present in tissue. Therefore, the increase in infectious diseases directly boosts the development of the in-situ hybridization market. For instance, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. This ongoing rise in infectious diseases is a significant factor propelling the growth of the in-situ hybridization market.
Which Segment Types Are Examined In The In Situ Hybridization Market Segment Study?
The in situ hybridization market covered in this report is segmented –
1) By Product: Analytical Instruments, Kits and Reagents, Software and Services
2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)
3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)
4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases
5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes
Subsegments:
1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems
2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents
3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services
What Trends Are Transforming The In Situ Hybridization Market?
Companies active in the in situ hybridization market are concentrating on inventive product offerings, including HCR RNA-CISH (Hybridization Chain Reaction RNA Chromogenic in situ Hybridization), to boost their market profitability. Hybridization chain Reaction RNA chromogenic in situ hybridization is defined as a method facilitating the visualization of RNA molecules within cells and tissues, characterized by high resolution and sensitivity. As an illustration, Molecular Instruments (MI), a biotech entity originating from the California Institute of Technology, introduced HCR RNA-CISH in February 2023. This launch aimed to improve automated chromogenic in situ hybridization (ISH) workflows that rely on RNAscope. These HCR RNA-CISH kits deliver superior performance compared to current chromogenic in situ hybridization methods, offering double the turnaround time and half the cost. Additionally, the solution includes inherent support for IHC (Immunohistochemistry) codetection and comprehensive compatibility across all leading automation platforms.
Which Players Are Part Of The Competitive Landscape Of The In Situ Hybridization Market?
Major companies operating in the in situ hybridization market are Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Qiagen, Bio-Techne Corporation, Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, NanoString Technologies Inc., Visiopharm A/S
Get The Full In Situ Hybridization Market Report:
https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report
Which Region Represents The Largest Share Of The In Situ Hybridization Market?
North America was the largest region in the in situ hybridization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized In Situ Hybridization Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp
Browse Through More Reports Similar to the Global In Situ Hybridization Market 2026, By The Business Research Company
Hybrid Seeds Market Report 2026
https://www.thebusinessresearchcompany.com/report/hybrid-seeds-global-market-report
Biocomposites Market Report 2026
https://www.thebusinessresearchcompany.com/report/biocomposites-global-market-report
Hybrid Cloud Market Report 2026
https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model